US-based biopharmaceutical company Acadia Pharmaceuticals's glaucoma collaboration partner Allergan has advanced a new additional drug candidate into preclinical development for the treatment of glaucoma. Acadia CEO Uli Hacksell said that ...
Tags: Preclinical Development, Allergan
A low-power Thunderbolt interconnect for smartphones and tablets is in the works, but the wired technology may not thrive if consumers prefer products using the wireless WiGig specification for data transfers. There is a need for faster ...
Tags: Low-Power Thunderbolt, Tablets, Smartphones
Danish biotechnology company Zealand Pharma and partner, the Swiss pharma group Helsinn have jointly cHelsinn's Phase IIa study with elsiglutide for the prevention of chemotherapy-induced diarrhea in cancer patients has been completed with ...
Tags: Health, Medicine, biotechnology
MannKind has completed the Phase 3 clinical study of Afrezza (insulin human [rDNA origin]) in patients with type 1 diabetes and expects to release the data in the summer of 2013. Administered using MannKind's next-generation inhaler, the ...
With an eye on next year's European elections, Digital Agenda Commissioner Neelie Kroes on Thursday called on the European Parliament to support her longstanding plans to end roaming charges and guarantee net neutrality. Though contrary ...
Tags: Computer Products
Lilliputian Systems, Inc., a developer of portable power products for consumer electronics, announced today that Nectar, a revolutionary portable power system, won first place in the Mobile Consumer Electronics Accessories category at the ...
Tags: Nectar, Mobile Power System, CTIA
The AidPod for ColaLife has all the right components to become the packaging system that definitively demonstrates to the world that packaging can not only add value to consumers' lives, but it can actually save lives. Recently garnering ...
Clinical-stage pharmaceutical company Cempra has received a notification of patent allowance from the US Patent and Trademark Office (USPTO) for taksta loading dose formulation. With the possibility for extension, the patent entitled ...
Facebook is reportedly pulling out of acquisition negotiations with mobile app provider Waze, opening the door for a Google buy. Citing unnamed sources,All Things D reported today that talks between Facebook and crowd-sourced mapping app ...
The U.S. government should bar foreign companies that repeatedly steal or use stolen U.S. intellectual property from selling their products in the country, a new report recommended. About US$300 billion worth of intellectual property is ...
Tags: US, Foreign Firms, Intellectual Property
The US Food and Drug Administration (FDA) has cleared Omeros' investigational new drug application (IND) for OMS824 in Huntington's disease. OMS824 is developed to selectively inhibit phosphodiesterase 10 enzyme that is expressed in areas ...
Tags: Omeros'IND, Medicine
John Adams, the toy company that designs and manufactures games, craft, science and doll products including Tiny Tears, Fuzzy Felt and Rubik’s, is hiring a product developer. "You will need to be a creative and Energetic team ...
Tags: John Adams, Job, Toys
Biogen Idec is seeking FDA approval for Plegridy (Peginterferon Beta-1a) as multiple sclerosis (MS) medication. The company submitted a biologics license application (BLA) to the FDA for its pegylated subcutaneous injectable candidate ...
Tags: Biogen IDEC, FDA Approval
ImmunoCellular Therapeutics has obtained US patent for methods of use of interleukin 13-receptor alpha 2 protein (IL-13Rα2) in cancer immunotherapy. IL-13 is an immune regulatory cytokine and IL-13Ra2 is highly and specifically ...
Tags: Immunocellular, US Patent, Alpha 2 Protein
The American Midwest is often thought of as the land of rolling plains, family values and, in recent years, shrinking economies. However, one industry stands to help the heartland get back on its feet: the construction industry. The ...